Agreement start date.

No definition available.

Name:	cgen_AgreementStartDate
Namespace Prefix:	cgen_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Agreement termination date.

+ References

No definition available.

+ Details

Name:	cgen_AgreementTerminationDate
Namespace Prefix:	cgen_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Amortization Of Cash Consideration Of Research And Development Funding Arrangement

+ References

No definition available.

+ Details

Name:	cgen_AmortizationOfCashConsiderationOfResearchAndDevelopmentFundingArrangement
Namespace Prefix:	cgen_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Gain or loss from conversion of exchange option and embedded derivatives under the Research and Development funding arrangement to shares, under mutual terms agreed by the parties for the agreement.

+ References

No definition available.

+ Details

Name:	cgen_GainLossInRespectToTerminationAndEquityConversionAgreement
Namespace Prefix:	cgen_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Liabilities Arising From Participation Rights

+ References

No definition available.

+ Details

Name:	cgen_LiabilitiesArisingFromParticipationRights
Namespace Prefix:	cgen_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Percentage of the cash consideration received by the Company or its affiliates from third parties to be paid back to investors.

+ References

No definition available.

+ Details

Name:	cgen_ParticipationRights
Namespace Prefix:	cgen_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Funding receivable as of a specified date for research and funding arrangements.

+ References

No definition available.

+ Details

Name:	cgen_ResearchAndDevelopmentArrangementReceivable
Namespace Prefix:	cgen_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Baize had the right at any time until June 30, 2015 to exchange the Amended Participation Rights for a number of the Company's ordinary shares, shares amount calculation.

+ References

No definition available.

+ Details

Name:	cgen_RightToExchangeTheAmendedParticipationRightsForOrdinarySharesCalculationDescription
Namespace Prefix:	cgen_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares in respect to the Termination and Equity Conversion Agreement issued during the period.

+ References

No definition available.

+ Details

Name:	cgen_StockIssuedDuringPeriodSharesTerminationAndEquityConversionAgreementIssues
Namespace Prefix:	cgen_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(2))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph i

-Subparagraph 2

-Article 4

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name:	us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-URI http://asc.fasb.org/extlink&oid=35706170&loc=SL5624171-113959

+ Details

Name:	us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of unrealized (holding) gain (loss) which is included in the statement of income (or changes in net assets) related to those liabilities still held at the reporting date for which fair value is measured on a recurring basis using significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The maximum number of shares that could be issued to net share settle a contract, if applicable. If a contract does not have a fixed or determinable maximum number of shares that may be required to be issued, disclose the fact that a potentially infinite number of shares could be issued to settle the contract.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 40

-Section 50

-Paragraph 5

-Subparagraph (b)(2),(c)

-URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90205-114008

+ Details

Name:	us-gaap_OptionIndexedToIssuersEquityShares
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise or strike price stated in the contract for options indexed to the issuer's equity shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 480

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(1)

-URI http://asc.fasb.org/extlink&oid=6940734&loc=d3e22047-110879

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 40

-Section 50

-Paragraph 5

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=6445032&loc=d3e90205-114008

+ Details

Name:	us-gaap_OptionIndexedToIssuersEquityStrikePrice1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

+ Details

Name:	us-gaap_PaymentOfFinancingAndStockIssuanceCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of customer funding recorded as an offset to costs incurred for a fixed-price, best-efforts research and development cost-sharing arrangement with the Federal Government.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 912

-SubTopic 730

-Section 25

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementWithFederalGovernmentCustomerFundingToOffsetCostsIncurred
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The number of shares or units of entity securities issued in the transaction in which equity securities were issued to pay for goods or nonemployee services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

RESEARCH AND DEVELOPMENT FUNDING ARRANGEMENTS AND OTHERS (Narrative) (Details) In Thousands, except Share data, unless otherwise specified	12 Months Ended					12 Months Ended
	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)	Dec. 31, 2014 ILS	Dec. 31, 2013 ILS	Dec. 31, 2014 Original Pipeline Funding Agreement [Member] USD ($)	Dec. 31, 2014 Amended Pipeline Funding Agreement [Member] USD ($)	Dec. 31, 2014 Termination and Equity Conversion Agreement [Member] ILS	Dec. 31, 2014 Minimum [Member] Amended Pipeline Funding Agreement [Member] USD ($)	Dec. 31, 2014 Maximum [Member] Amended Pipeline Funding Agreement [Member] USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Consideration received in funding arrangement						$ 5,000
Funding receivable						8,000
Options issued to agent						100,000
Warrant and option issuance costs						80
Change in fair value of liability with respect to outstanding options to non-employee		104	20
Right to exchange the Amended Participation Rights for ordinary shares, calculation description							(i) $ 13,000 less 50% of any cash consideration paid to Baize as Amended Participation Rights, divided by (ii) the average closing price of the Company’s ordinary shares during the twenty (20) trading days prior to the Actual Exchange Date (the “Exchange Price”)
Participation Rights							10.00%	5.00%
Price at which investors can exchange rights							$ 7.50		$ 3.00	$ 12.00
Ordinary shares eligible for purchase with warrants							500,000
Exercise price of warrants							$ 6.00
Number of shares to be issued upon exchange of Participation Rights							500,000
Financial income (expenses) related to embedded derivative	269	(811)	(588)
Researhc and development component	421	758
Amortization research and development component	337	230	130
Issuance of shares in respect to Termination and Equity Conversion Agreement, shares								1,600,000
Ordinary shares, par value per share				0.01	0.01			0.01
Financial expenses as a result of 2014 Baize Agreement	$ 792
Agreement, start date						Sep. 20, 2010	Apr. 21, 2013	Aug. 20, 2014
Agreement, termination date						Apr. 21, 2013	Aug. 20, 2014